Evidence-Based Complementary and Alternative Medicine

Research Article

Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts

Figure 1

Standard curves for calycosin glycosidase (a) and astragaloside (b).
(a)
(b)